Successful treatment of Type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus.
Coll
A P
AP
Morganstein
D
D
Jayne
D
D
Soos
M A
MA
O'Rahilly
S
S
Burke
J
J
D000328:Adult; D048909:Diabetes Complications; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D010956:Plasmapheresis / Q000379:methods*; D011239:Prednisolone / Q000008:administration & dosage; D016896:Treatment Outcome
D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D007328:Insulin; D011239:Prednisolone